First Savings Financial Group, Inc. Reports Financial Results For The Fiscal Year Ended September 30, 2025

First Savings Financial Group, Inc. Reports Financial Results For The Fiscal Year Ended September 30, 2025 GlobeNewswire October 29, 2025 JEFFERSONVILLE, Ind., Oct. 29, 2025 (GLOBE NEWSWIRE) — First Savings Financial Group, Inc. (NASDAQ: FSFG – news) (the “Company”), the holding company for First Savings Bank (the “Bank”), today reported net income of $23.2 million, […]

Food Lion Removes Yellow and White Flesh Peaches due to Supplier Recall

Food Lion Removes Yellow and White Flesh Peaches due to Supplier Recall GlobeNewswire October 29, 2025 SALISBURY, N.C., Oct. 29, 2025 (GLOBE NEWSWIRE) — Food Lion is notifying customers of a voluntary recall initiated by its supplier, Moonlight Companies, on yellow and white flesh peaches, due to potential contamination with Listeria monocytogenes. The recall affects

FLUOR CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Urges Fluor Stockholders to Contact the Firm Regarding their Rights Before November 14th

(NYSE:FLR), Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Fluor (FLR) To Contact Him Directly To Discuss Their Options If you purchased or acquired Fluor securities between February 18, 2025 and July 31, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner

FLUOR CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Urges Fluor Stockholders to Contact the Firm Regarding their Rights Before November 14th

FLUOR CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Urges Fluor Stockholders to Contact the Firm Regarding their Rights Before November 14th GlobeNewswire October 29, 2025 Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Fluor (FLR) To Contact Him Directly To Discuss Their Options If you purchased or

Amneal Receives U.S. FDA Tentative Approval for Beclomethasone Dipropionate HFA Inhalation Aerosol

Amneal Receives U.S. FDA Tentative Approval for Beclomethasone Dipropionate HFA Inhalation Aerosol Company's first metered-dose inhalation (MDI) product and establishes a new growth vector for the Affordable Medicines segment GlobeNewswire October 29, 2025 BRIDGEWATER, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) — Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) today announced that the U.S. Food and

Sherman Portfolios Releases the Sherman Launch System (SLS), Delivering Real-Time Market Signals and Research for Financial Advisors

Sherman Portfolios Releases the Sherman Launch System (SLS), Delivering Real-Time Market Signals and Research for Financial Advisors GlobeNewswire October 29, 2025 COEUR D'ALENE, Idaho, Oct. 29, 2025 (GLOBE NEWSWIRE) — Sherman Portfolios, LLC (SPL), an SEC-registered investment adviser, today announced the release of the Sherman Launch System (SLS) — a subscription software platform that delivers

Shenandoah Telecommunications Company Reports Third Quarter 2025 Results

Shenandoah Telecommunications Company Reports Third Quarter 2025 Results GlobeNewswire October 29, 2025 EDINBURG, Va., Oct. 29, 2025 (GLOBE NEWSWIRE) — Shenandoah Telecommunications Company (“Shentel” or the “Company”) (Nasdaq: SHEN) announced third quarter 2025 financial and operating results. Third Quarter 2025 Highlights Glo Fiber Expansion Markets revenue grew 41.1% compared to the third quarter of 2024

Hawthorn Bancshares Announces Cash Dividend

(NASDAQ:HWBK), JEFFERSON CITY, Mo., Oct. 29, 2025 (GLOBE NEWSWIRE) — Hawthorn Bancshares, Inc. (NASDAQ: HWBK) announced today that its Board of Directors approved a quarterly cash dividend of $0.20 per common share, payable January 1, 2026 to shareholders of record at the close of business on December 15, 2025. About Hawthorn Bancshares, Inc. Hawthorn Bancshares,

Hawthorn Bancshares Announces Cash Dividend

Hawthorn Bancshares Announces Cash Dividend GlobeNewswire October 29, 2025 JEFFERSON CITY, Mo., Oct. 29, 2025 (GLOBE NEWSWIRE) — Hawthorn Bancshares, Inc. (NASDAQ: HWBK) announced today that its Board of Directors approved a quarterly cash dividend of $0.20 per common share, payable January 1, 2026 to shareholders of record at the close of business on December

Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team

Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team Renowned pain management and medical technology leader to accelerate Glucotrack's strategy for integrated glucose monitoring applications, building on Company's 2024 expansion into epidural monitoring GlobeNewswire October 29, 2025 RUTHERFORD, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) — Glucotrack, Inc.(“Glucotrack”, or

Scroll to Top